Featured Celebrex ®
Attorney
" None Listed At This Time"
Try selecting a Celebrex ®
Attorney link from the list below
Welcome to the Celebrex ® Attorney
Page
About Celebrex
Celebrex, the brand name of the generic drug celecoxib, was approved
by the U.S. Food and Drug Administration (FDA) on December 31, 1998, for
the treatment of rheumatoid arthritis and osteoarthritis and, on December
23, 1999, as a drug treatment aimed at reducing the number of intestinal
polyps in patients with a rare genetic disorder called familial adenomatous
polyposis (FAP), an inherited disorder that, if left untreated, always
develops into colon cancer. Celebrex is a non-steroidal anti-inflammatory
drug (NSAID), and is in a class of drugs commonly referred to as "Cox-2
inhibitors."
Celebrex In The News
On! December 17th, 2004 the National Institutes of Health (NIH) announced
that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex) for
all participants in a large colorectal cancer prevention clinical trial
conducted by the National Cancer Institute (NCI). The study, called the
Adenoma Prevention with Celecoxib (APC) trial, was stopped because analysis
by an independent Data Safety and Monitoring Board (DSMB) showed a 2.5-fold
increased risk of major fatal and non-fatal cardiovascular events for participants
taking the drug compared to those on a placebo.
In the APC clinical trial, patients taking 400 mg. of Celebrex twice
daily had a 3.4 times greater risk of cardiovascular events compared to
placebo. For patients in the trial taking 200 mg. of Celebrex twice daily,
the risk was 2.5 times greater. The average duration of treatment in the
trial was 33 months. However, a similar ongoing study comparing Celebrex
400 mg! . once a day versus placebo, in patients followed for a similar period
of time, has not shown increased risk.
Both the manufacturer of Celebrex (Pfizer) and the FDA are currently
evaluating the data from these studies.
Also on December 17, the FDA asked Pfizer, Inc. to voluntarily suspend
direct-to-consumer advertising on Celebrex during the time the FDA is obtaining
and evaluating the new and conflicting scientific data on adverse events
associated with the drug. FDA also requested Pfizer change the information
provided to physicians to reflect the recommendations FDA made encouraging
physicians to consider alternative therapies as they evaluate their individual
patient needs. Pfizer agreed to suspend its Celebrex promotion and to craft
appropriate detailing to physicians that reflects the uncertainty of scientific
data currently available.
How a Celebrex Attorney Can Help
As with any situation involving a dangerous or defective product, if
you have taken celebrex you should speak with an experienced Celebrex Attorney
who will evaluate your case with you, to ensure that your legal rights
are fully assessed and protected. A Celebrex Attorney can explain what
you can expect at every step of your personal injury case, and will take
action on your behalf -- researching the law, interviewing witnesses, collecting
records, conferring with expert consultants, planning legal strategy, and
negotiating with insurers and opposing counsel -- all with an eye toward
strengthening your position and ensuring your fair recovery.
Use the links below
to Find Experienced
Celebrex Attorney Near
You
Get the right Celebrex
Attorney - It Does Make a Difference !
